❭ Action plans and policy papers ❭

Action plans and policy papers

Protocol: An anonymized GWAS to urgently query host genetic predisposition to severe COVID-19 (SARS-CoV-2 infection) lung disease (open as PDF)
Criteria for excellent research in KIT – report from work group (in Norwegian only) (open as PDF)
User involvement: possible models in KIT. Report from work group (in Norwegian only) (open as PDF)
Handlingsplan for forskning i KIT for 2021 (open as PDF)
Handlingsplan for forskning i KIT for 2022 (open as PDF)
Handlingsplan for forskning i KIT for 2023 (open as PDF)
 
Scroll to top

Home Surgery, Inflammatory Diseases and Transplantation

  • Surgical research
  • Translational research
  • Rheumatology, Dermatology and Infectious Diseases
  • Transplantation medicine
  • Research Institute for Internal Medicine
  • Research staff
  • Research Management and the Research Committee
  • Strategic Protocol Committee
  • Annual reports from the Research Groups
  • Action plans and policy papers
  • Centre for Clinical Trials in KIT
  • Publications KIT
  • Surgery and Specialized Medicine (new from 2025 onwards)

Recent publications

Noor D, Baco E, Lauritzen PM, Berge V, Galtung KF, Jacewicz M, Eri LM, Rud E (2025)
The Effect of Preoperative Magnetic Resonance Imaging on Long-term Oncological Outcomes Following Radical Prostatectomy-A 12-year Follow-up of a Randomized Controlled Trial
Eur Urol Open Sci, 79, 79-86
DOI 10.1016/j.euros.2025.07.005, PubMed 40823001

Newsome P, Tacke F, Wedemeyer H, Rimassa L, Berzigotti A, Karlsen TH, Ratziu V (2025)
From the Editor's Desk.
J Hepatol, 83 (3), 605-608
DOI 10.1016/j.jhep.2025.07.015, PubMed 40819886

Ruban A, Prudyus V, Zolnikova A, Petrovski BÉ, Petrovski G, Grzybowski A, Lytvynchuk LM (2025)
Foveal actual defect (FAD): A novel OCT biomarker for prognosis and surgical decision support in idiopathic full-thickness macular hole
Asia Pac J Ophthalmol (Phila), 100232 (in press)
DOI 10.1016/j.apjo.2025.100232, PubMed 40818750

Hoffmann-Vold AM, Distler O, authors (2025)
Further progression in patients with systemic sclerosis-associated interstitial lung disease - Authors' reply
Lancet Rheumatol (in press)
DOI 10.1016/S2665-9913(25)00217-6, PubMed 40816307